Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
---|---|
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00213785 |
A study of plasmatic concentrations of endothelin-1 (ET1), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in acute ischemic stroke.
Condition |
---|
Stroke |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
Clinique neurologique - Service des maladies du système nerveux et du muscle - Hôpitaux Universitaires de Strasbourg, Hôpital Civil | |
Strasbourg, France, 67091 |
Principal Investigator: | Andoni Echanz-Laguna, MD | Hopitaux Universitaires de Strasbourg |
Study ID Numbers: | 2558 |
Study First Received: | September 13, 2005 |
Last Updated: | November 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00213785 |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
AreET1 ANP BNP pronostic markers of stroke |
Natriuretic Peptide, Brain Cerebral Infarction Stroke Vascular Diseases Brain Ischemia Central Nervous System Diseases |
Brain Infarction Ischemia Brain Diseases Infarction Cerebrovascular Disorders |
Natriuretic Agents Therapeutic Uses Physiological Effects of Drugs Nervous System Diseases |
Cardiovascular Diseases Cardiovascular Agents Pharmacologic Actions |